Clinical Trial Update: Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating blue light resection for high-risk non-muscle invasive bladder cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Snippet

Sponsor: Johns Hopkins University | Conditions: Bladder Cancer | Phase 3 | Status: RECRUITING